Qiang Liu
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tianjin Medical University General Hospital · Sunyat-sen Memorial Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qiang Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:51 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07544056 · A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast CancerBeBetter Med Inc · recruiting · Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer · principal investigator
- N/ANCT07095023 · Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Cancers · principal investigator
- Ph1/Ph2NCT07022197 · Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune DiseasesTianjin Medical University General Hospital · recruiting · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, NMO Spectrum Disorder, Myasthenia Gravis · principal investigator
- Ph2NCT06685796 · A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast CancerBeBetter Med Inc · completed · Advanced Triple-Negative Breast Cancer · principal investigator
- Ph2NCT06445400 · A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · HER2-positive Breast Cancer · principal investigator
- N/ANCT06228781 · Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple SclerosisTianjin Medical University General Hospital · not yet recruiting · Multiple Sclerosis · principal investigator
- Ph2NCT05945368 · A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · HER2-positive Breast Cancer · study chair
- Ph2NCT05862610 · The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · not yet recruiting · Breast Neoplasm · study chair
- Ph1NCT05792462 · Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum DisordersTianjin Medical University General Hospital · active not recruiting · NMO Spectrum Disorder · principal investigator
- Ph2NCT05263869 · A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer PatientsShanghai Miracogen Inc. · unknown · Breast Cancer With Liver Metastases · principal investigator
- N/ANCT04891731 · Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · Hormone Receptor-positive Breast Cancer · principal investigator
- Ph2/Ph3NCT04803539 · A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Cancer · principal investigator
- Ph2NCT04501523 · A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Triple-negative Breast Cancer · principal investigator
- N/ANCT04076111 · Patterns of Breast Cancer Management and Prognosis of Breast Cancer in ChinaFengxi Su · unknown · Breast Cancer · study chair
- Ph1NCT04060511 · A Study of HS-10342 in Patients With Advanced Solid TumorJiangsu Hansoh Pharmaceutical Co., Ltd. · completed · Advanced Solid Tumor · principal investigator
- N/ANCT03260192 · Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · Breast Cancer · principal investigator
- Ph3NCT02062489 · Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer PatientsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · Breast Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Advanced X-ray Digital Dental Imaging SystemR43DE015895 · NIDCR · SUN INNOVATIONS COMPANY · fiscal years 2004 · $100,000 awarded in 2004Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:51 UTC. The ranking covers the 200 most relevant of 55 PubMed records, and a shared surname and initials can bring in a namesake. All 55 on PubMed
- 2,392 citationsRCR 180.8
- 358 citationsRCR 18.5
- FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer.Clin Cancer Res · 2014280 citationsRCR 7.9
- 240 citationsRCR 15.8
- Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial.J Immunother Cancer · 2020154 citationsRCR 5.6
- 153 citationsRCR 6.8
- Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.Clin Cancer Res · 2020135 citationsRCR 4.9
- Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.Nat Med · 2024134 citationsRCR 14.2
- 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.J Natl Cancer Inst · 2017115 citationsRCR 3.5
- Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy.Cancer Epidemiol Biomarkers Prev · 2007112 citationsRCR 3.3